close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

1.590 -0.080 (-4.79%)
Streaming Delayed Price Updated: 12:17 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,917,591
Open 1.680
Bid (Size) 1.590 (9,100)
Ask (Size) 1.600 (23,200)
Prev. Close 1.670
Today's Range 1.580 - 1.680
52wk Range 1.150 - 6.770
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Humacyte, Inc. (NASDAQ: HUMA) Announces $60 Million Registered Direct Offering of Common Stock and Warrants
Via Investor Brand Network
D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering
Via ACCESS Newswire

Performance

YTD
-69.3%
-69.3%
1 Month
-24.3%
-24.3%
3 Month
-29.6%
-29.6%
6 Month
+26.2%
+26.2%
1 Year
-68.6%
-68.6%

More News

Read More
Top stock movements in today's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
An Overview of Humacyte's Earnings
Via Benzinga
Exploring Humacyte's Earnings Expectations
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Tuesday's session: gap up and gap down stocks
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback
Via Benzinga
Topics ETFs Economy
Which stocks are experiencing notable movement on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Monday's session: gap up and gap down stocks
Via Chartmill
Humacyte Inc (NASDAQ:HUMA) Q2 2025 Earnings: Revenue Misses Estimates, Shares Drop 9.9% in Pre-Market
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Humacyte Posts Q2 Revenue Miss
Via The Motley Fool
Topics Intellectual Property
Earnings Scheduled For August 11, 2025
Via Benzinga
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Gold Falls 1%; ProKidney Shares Spike Higher
Via Benzinga
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Gapping stocks in Tuesday's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Earnings Scheduled For May 13, 2025
Via Benzinga

Frequently Asked Questions

Is Humacyte, Inc. - Common Stock publicly traded?
Yes, Humacyte, Inc. - Common Stock is publicly traded.
What exchange does Humacyte, Inc. - Common Stock trade on?
Humacyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Humacyte, Inc. - Common Stock?
The ticker symbol for Humacyte, Inc. - Common Stock is HUMA on the Nasdaq Stock Market
What is the current price of Humacyte, Inc. - Common Stock?
The current price of Humacyte, Inc. - Common Stock is 1.590
When was Humacyte, Inc. - Common Stock last traded?
The last trade of Humacyte, Inc. - Common Stock was at 11/03/25 12:17 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today